Home / Cancer and immune system / Secukinumab
ATC L04AC10 · Immunosuppressants
Secukinumab shortage
As of 31 Oct 2026, Secukinumab has a reported shortage in 2 of the 5 countries we track (Austria, Belgium), covering 2 products.
Countries2/5
Products2packs or presentations
Short since4 Aug 20233.2 years ago
Earliest return12 Nov 2026company estimate
No return date1products
Main reasonIncreased demand
Timeline
AustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Cosentyx 150 mg Injektionslösung in einer Fertigspritze, 1 Stück | Novartis Europharm Limited | 4 Aug 2023 | not given | Increased demand Erhöhter Mehrbedarf |
| BE | Cosentyx 150 mg inj. sol. s.c. pre-filled pen 2 x 1 ml | Novartis Europharm | 26 Oct 2026 | 12 Nov 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.